(Google Translation)
The Zaoui brothers arrogate more than $ 100 billion merger
The most famous M & A two former brothers 'enemies' are hands on the European market for mergers and acquisitions. In one year, the brand Zaoui, launched by the two "deal makers" after leaving Morgan Stanley and Goldman Sachs, already appears prominently in the charts in the expensive M & A specialists. Their "boutique" consulting, Zaoui & Co, claims 16% of market share in mergers and acquisitions in Europe with a total of $ 111 billion of transactions advised on 721 billion of transactions reported in January by Dealogic (taking into account all of the GlaxoSmithKline / Novartis operation).
On February 11, after months of silence, Michael Zaoui, who retired six years ago co-director of mergers and acquisitions department of Morgan Stanley, and Yoel Zaoui that of global head of M & A at Goldman Sachs in 2012, have thus a comeback in the European market via France. That day, L'Oréal and Nestlé announced they untie their bonds. While all the rumors were betting on a passage from the French cosmetics group under Swiss flag, L'Oreal buys 8% stake to Nestlé. And the Bettencourt family increases its weight in the cosmetic group to over 33%. Eight days later, their name emerges in the deal that makes the most debate in France: the entrance of the Chinese Dongfeng Peugeot capital. The Zaoui brothers advise the holding family that risk dilution. This one will eventually win a weight equivalent to the capital of the state and the Chinese.
The strategy of "Pac-Man"
Since the strategy of "Pac-Man" (cons-attack, trying to redeem his predator) they initiated together to defend Elf Total face in 1999 against Sanofi and Aventis in 2004, the brothers are masters against the - hostile bids , complex and intricate deals (Gucci PPR and LVMH prey in 2004), most often in different camps (Alcan coveted by Pechiney in 2003, Arcelor Mittal to win in 2006). Their list of January so do not break the rule. Less than two months after having advised the Peugeot family, they supported Lafarge in its merger of equals with the Swiss Holcim. And a few weeks later, they curled their biggest deal by attending GlaxoSmithKline. For $ 57 billion, it unwound a triple operation with Novartis: he yielded his wallet oncology, vaccines classier him and together they created a joint venture